Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 10 X users

patent: 4 patents

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 86 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 32,344 followers.

RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…

08 Apr 2019

Reply Repost Favourite

RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…

08 Apr 2019

Reply Repost Favourite

Excellent way to inhibit Tregs (https://t.co/v0qad90xfB), which probably contribute to more inhibition of the anti-tumor response since they directly attack anti-tumor T cells.

07 Apr 2019

Reply Repost Favourite

RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…

07 Apr 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.